Medi Assist Healthcare Services Limited has significantly accelerated its cashless healthcare processing capabilities, reporting that more than 50% of hospital pre-authorisations are now approved in under five minutes. This milestone follows major upgrades to its artificial intelligence platforms, specifically MAven Intelligent Document Processing (MAven IDP), MAGnum, and MAven Guard. These technological enhancements aim to reduce friction in patient admissions and strengthen claims integrity for insurers and healthcare providers across India.

The operational improvements have yielded measurable outcomes in customer satisfaction and efficiency. Medi Assist TPA, a wholly owned subsidiary of the company, recorded a Net Promoter Score (NPS) of 67, reflecting gains in speed and consistency. Additionally, calls from claimants dropped by over 60%, indicating a smoother claims journey with fewer manual interventions required.

Satish Gidugu, CEO of Medi Assist Group, stated that the company’s strategy focuses on simplifying the entire cashless journey, from admission to fraud detection. He noted that each platform upgrade removes points of friction between patients and necessary care, extending the approach previously used in the discharge process with Raksha Prime.

Platform Enhancements

The upgrades target distinct stages of the healthcare administration workflow:

MAven IDP reads and standardises hospitalisation documents, providing claims teams with structured clinical summaries. This enables faster and more consistent decision-making, allowing patients to be admitted sooner. Meanwhile, MAGnum provides hospitals with real-time visibility into whether a patient qualifies for Raksha Prime, the status of every claim, and which cases have been settled and paid. This transparency reduces queries and facilitates faster admissions.

MAven Guard’s latest release enhances claims integrity by detecting fraud, waste, and abuse with up to 50% greater precision. This protects the ecosystem while ensuring genuine claims are processed without delay.

What the Numbers Show

The reduction in claimant calls by over 60% alongside an NPS of 67 suggests that automation is effectively resolving issues before they require human intervention. The ability to approve more than 50% of pre-authorisations in under five minutes indicates a shift from manual, document-heavy processes to automated, data-driven approvals, directly impacting patient wait times and hospital operational efficiency.

In a significant expansion, MAven IDP is now available to insurers and healthcare providers beyond the Medi Assist Group, extending its impact to the broader healthcare ecosystem in India.

HDFC Mutual Fund reduced its shareholding in medi assist healthcare by 2.04% through open market sales on July 20, 2026. The aggregate holding of the mutual fund schemes decreased to 5.592% of the paid-up equity share capital, down from a previously disclosed 7.63% as of September 13, 2024. This change was communicated to the company in compliance with Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The disclosure, submitted by Dinesh Bhakade, Lead – Compliance Governance at HDFC Asset Management Company Limited, detailed the specific shares sold. The transaction involved the sale of 11,89,737 equity shares carrying voting rights. Prior to the sale, the fund held 53,67,378 shares, representing 7.185% of the total voting capital based on the latest filing. Following the disposal, the holding stands at 41,77,641 shares.

The paid-up equity share capital of Medi Assist Healthcare Services Limited is reported as ₹37,35,09,210, comprising 7,47,01,842 equity shares of ₹5 each. The acquirer clarified that it does not belong to the promoter or promoter group of the target company. The shares of Medi Assist Healthcare Services Limited are listed on BSE Limited and National Stock Exchange of India Limited.

Shareholding Details

The mode of acquisition was specified as an open market transaction. The total diluted share or voting capital of the company was reported as not applicable (N.A.) for the purposes of this calculation.